Lifestance Health
LFST
194 hedge funds and large institutions have $1.81B invested in Lifestance Health in 2025 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 75 increasing their positions, 58 reducing their positions, and 25 closing their positions.
79% more call options, than puts
Call options by funds: $7.73M | Put options by funds: $4.32M
56% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 25
29% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 58
7% more funds holding
Funds holding: 181 → 194 (+13)
0.53% more ownership
Funds ownership: 89.28% → 89.81% (+0.53%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less capital invested
Capital invested by funds: $2.29B → $1.81B (-$481M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$26.4M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$14M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.5M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$7.8M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$6.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$28.3M |
| 2 |
Jennison Associates
New York
|
-$5.93M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$5.91M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.96M |
| 5 |
Millennium Management
New York
|
-$4.58M |
LFST Hedge Fund Activity: Q2 2025 in Review
194 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Lifestance Health (LFST) for Q2 2025, worth a combined $1.81B — down 21% from $2.29B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new LFST positions and 25 closed out — a net gain of 14 holders — while 75 added to existing stakes and 58 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $26.4M. The largest seller was Fidelity Investments, cutting an estimated $28.3M.
- 194 institutional investors held Lifestance Health (LFST) as of Q2 2025, up from 181 in Q1 2025.
- Funds reported $1.81B of Lifestance Health stock for Q2 2025, down 21% quarter-over-quarter.
- 39 funds opened new Lifestance Health positions in Q2 2025 and 25 closed out, a net change of +14 holders.
- The largest Lifestance Health buyer in Q2 2025 was T. Rowe Price Investment Management, an estimated $26.4M added.
- The largest Lifestance Health seller in Q2 2025 was Fidelity Investments, an estimated $28.3M sold.
Based on aggregated 13F filings for Q2 2025.